| P50 | author | Kelly R. Magliocca | Q89464035 |
| P2093 | author name string | Shi-Yong Sun | |
| | Dong M Shin | |
| | Dongsheng Wang | |
| | Zhongliang Hu | |
| | Sungjin Kim | |
| | Nabil F Saba | |
| | Zhengjia Chen | |
| | Guoqing Qian | |
| | Zhuo G Chen | |
| | Sreenivas Nannapaneni | |
| P2860 | cites work | Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States | Q22306233 |
| | Targeting the hepatocyte growth factor-cMET axis in cancer therapy | Q24606259 |
| | Optimization of biotinyl-tyramide-based in situ hybridization for sensitive background-free applications on formalin-fixed, paraffin-embedded tissue specimens | Q24800680 |
| | Human papillomavirus and survival of patients with oropharyngeal cancer. | Q27851567 |
| | Targeting the c-Met signaling pathway in cancer | Q28246393 |
| | HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes | Q28254780 |
| | Comprehensive genomic characterization of head and neck squamous cell carcinomas | Q28256121 |
| | Case-control study of human papillomavirus and oropharyngeal cancer | Q28301695 |
| | The mutational landscape of head and neck squamous cell carcinoma | Q29614654 |
| | Novel insight into mutational landscape of head and neck squamous cell carcinoma | Q30441193 |
| | The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma | Q30494514 |
| | Combination of anti-HER3 antibody MM-121/SAR256212 and cetuximab inhibits tumor growth in preclinical models of head and neck squamous cell carcinoma | Q33875560 |
| | Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus | Q34127590 |
| | siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells | Q34227843 |
| | The association between EGFR variant III, HPV, p16, c-MET, EGFR gene copy number and response to EGFR inhibitors in patients with recurrent or metastatic squamous cell carcinoma of the head and neck | Q34639763 |
| | Human papillomavirus 16 oncoprotein regulates the translocation of β-catenin via the activation of epidermal growth factor receptor | Q34944436 |
| | Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus | Q35000164 |
| | Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas | Q35008028 |
| | Wild-type p53 controls cell motility and invasion by dual regulation of MET expression | Q35180856 |
| | Assembly and initial characterization of a panel of 85 genomically validated cell lines from diverse head and neck tumor sites. | Q35589619 |
| | Mechanisms of human papillomavirus-induced oncogenesis. | Q35915935 |
| | Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia | Q36223356 |
| | Molecular biology of human papillomavirus infection and cervical cancer | Q36441612 |
| | miR-34 cooperates with p53 in suppression of prostate cancer by joint regulation of stem cell compartment | Q37706146 |
| | Human papillomavirus oncoproteins: pathways to transformation | Q37769103 |
| | MET: a promising anticancer therapeutic target | Q38008247 |
| | The Met receptor tyrosine kinase: a key player in oncogenesis and drug resistance | Q38175267 |
| | Biological, diagnostic and therapeutic relevance of the MET receptor signaling in head and neck cancer. | Q38208571 |
| | C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell | Q38212355 |
| | De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis of current clinical trials. | Q38236897 |
| | c-Met expression is a marker of poor prognosis in patients with locally advanced head and neck squamous cell carcinoma treated with chemoradiation. | Q38392890 |
| | Human Papillomavirus-Associated Oropharyngeal Cancer: Defining Risk Groups and Clinical Trials | Q38583292 |
| | Combined MET inhibition and topoisomerase I inhibition block cell growth of small cell lung cancer | Q39044577 |
| | Head neck squamous cell carcinoma c-Met⁺ cells display cancer stem cell properties and are responsible for cisplatin-resistance and metastasis | Q39608945 |
| | Therapeutic potential of recombinant p53 overexpression in breast cancer cells expressing endogenous wild-type p53. | Q41040883 |
| | A recombinant adenovirus expressing wild type p53 induces apoptosis in drug-resistant human breast cancer cells: a gene therapy approach for drug-resistant cancers. | Q41074771 |
| | Frequent hepatocyte growth factor overexpression and low frequency of c-Met gene amplification in human papillomavirus-negative tonsillar squamous cell carcinoma and their prognostic significances | Q42219837 |
| | Hepatocyte growth factor and c-Met in cervical intraepithelial neoplasia: overexpression of proteins associated with oncogenic human papillomavirus and human immunodeficiency virus | Q45729463 |
| | Comparison of in-situ hybridization, direct and indirect in-situ PCR as well as tyramide signal amplification for the detection of HPV. | Q50519722 |
| | Cancer of the head and neck is the sixth most common cancer worldwide | Q83102756 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P304 | page(s) | 21-32 | |
| P577 | publication date | 2016-07-20 | |
| P1433 | published in | European Journal of Cancer | Q332260 |
| P1476 | title | Human papillomavirus oncoprotein E6 upregulates c-Met through p53 downregulation | |
| P478 | volume | 65 | |